Invention Grant
- Patent Title: Interleukin-2 fusion proteins and uses thereof
-
Application No.: US15024792Application Date: 2014-09-24
-
Publication No.: US10781242B2Publication Date: 2020-09-22
- Inventor: Fahar Merchant
- Applicant: Medicenna Therapeutics, Inc.
- Applicant Address: CA Toronto, Ontario
- Assignee: Medicenna Therapeutics Inc.
- Current Assignee: Medicenna Therapeutics Inc.
- Current Assignee Address: CA Toronto, Ontario
- Agency: Morgan, Lewis & Bockius LLP
- International Application: PCT/CA2014/050917 WO 20140924
- International Announcement: WO2015/042707 WO 20150402
- Main IPC: A61K38/17
- IPC: A61K38/17 ; A61K38/20 ; C07K14/55 ; C07K14/47 ; C07K19/00 ; C12N5/10 ; C12N15/63 ; C07K14/82 ; C12N5/071 ; A61K38/00
Abstract:
The present invention relates to interleukin-2 fusion proteins. More specifically, the invention provides, in part, fusion proteins that include a interleukin-2 protein moiety joined to a Bcl-2 family member protein moiety.
Public/Granted literature
- US20160229901A1 INTERLEUKIN-2 FUSION PROTEINS AND USES THEREOF Public/Granted day:2016-08-11
Information query
IPC分类:
